Home - Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
amicusrx.đp.cc
Redefining Expectations in Rare Disease About Amicus Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Learn More About BioMarin We are guided by people living with rare diseases across the globe.
About Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
This is an independent đp.cc directory entry for Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases. The destination website remains operated by its respective owner.
What this listing is about
The following topics were found directly in the stored title or description for this destination.
How this link works
amicusrx.đp.cc is a short address in the đp.cc directory. Opening it uses the configured proxied view mode. The direct destination is amicusrx.com, which remains under the control of its owner.
đp.cc provides this directory page and short-link service. Destination content, products, policies and availability are controlled by the destination website and its owner.
Report this link